FCS has opened a new state-of-the-art facility at 2824 Enterprise Road, Orange City, FL 32763-8428 to provide comprehensive treatments and a variety of services to adults with cancer, blood disorders and other diseases.
FCS continues to advance the treatment of gastrointestinal and genitourinary cancers, as evidenced by participation at two global gatherings held this month and sponsored by the American Society of Clinical Oncology (ASCO®).
A best practices program developed at Florida Cancer Specialists & Research Institute (FCS) has been shown to improve outcomes for adult patients prescribed selinexor for the treatment of relapsed/refractory multiple myeloma (RRMM).
Senior Vice President & Data Officer Trevor Heritage, PhD will share learnings gained from the statewide practice’s development of an innovative propriety precision oncology platform at the Precision Medicine World Conference (PMWC® 2024) being held this month in Santa Clara, California.
FCS Top News Updates
FCS Among First in Florida to Trial Next-Generation Immunotherapy for Castration-Resistant Prostate Cancer
Cancer Prevention OverviewFind out how you can reduce your risk of cancer through simple lifestyle changes and preventative measures.
FCS Welcomes Medical Oncologist Jacob L. BarishJacob Barish, MD now seeing patients at FCS Lake Nona Cancer Center and FCS Kissimmee.
FCS Expands Access To Cancer Care in Volusia CountyFCS has opened a new state-of-the-art facility at 2824 Enterprise Road, Orange City, FL 32763-8428 to provide comprehensive treatments and a variety of services to adults with cancer, blood disorders and other diseases.
Vulvar Cancer TreatmentFind effective treatment options for vulvar cancer. Learn about different approaches and therapies to fight this type of cancer.
Blood Cancers and Itchy SkinSkin rashes, bruises and itchy skin can be signs of something wrong internally. Key signs of blood cancer you should watch for on your skin.
FCS Contributing to Global Advancements for Treatment of Gastrointestinal and Genitourinary CancersFCS continues to advance the treatment of gastrointestinal and genitourinary cancers, as evidenced by participation at two global gatherings held this month and sponsored by the American Society of Clinical Oncology (ASCO®).
FCS Best Practices Program Improves Treatment Response and Survival for Patients with Multiple MyelomaA best practices program developed at Florida Cancer Specialists & Research Institute (FCS) has been shown to improve outcomes for adult patients prescribed selinexor for the treatment of relapsed/refractory multiple myeloma (RRMM).
FCS Innovations in Precision Oncology Informatics Showcased at World ConferenceSenior Vice President & Data Officer Trevor Heritage, PhD will share learnings gained from the statewide practice’s development of an innovative propriety precision oncology platform at the Precision Medicine World Conference (PMWC® 2024) being held this month in Santa Clara, California.